PAXLOVID (NIRMATRELVIR AND RITONAVIR) FILM-COATED TABLETS

Pfizer Manufacturing Deutschland GmbH (GERMANY)Pfizer Ireland Pharmaceuticals Unlimited Company (IRELAND)Hetero Labs Limited (INDIA)Hetero Drugs Limited (Ritonavir Premix) (INDIA)🇸🇬 Health Sciences Authority

Approval Date: Jan 7, 2026
Approval ID: 2dfa7ad3516256ac
Company: Pfizer Manufacturing Deutschland GmbH (GERMANY)Pfizer Ireland Pharmaceuticals Unlimited Company (IRELAND)Hetero Labs Limited (INDIA)Hetero Drugs Limited (Ritonavir Premix) (INDIA)
Type: Therapeutic

Approval Details

Approval Id: 2dfa7ad3516256ac
Drug Name: PAXLOVID (NIRMATRELVIR AND RITONAVIR) FILM-COATED TABLETS
Product Name: PAXLOVID (NIRMATRELVIR AND RITONAVIR) FILM-COATED TABLETS
Approval Number: SIN17428P
Approval Date: 2026-01-07
Registrant: PFIZER PRIVATE LIMITED
Drug Type: Therapeutic
Forensic Classification: Prescription Only
Dosage Form: TABLET, FILM COATED
Route Of Administration: ORAL

Approved

Quick Info

Agency

HSA

Country

🇸🇬

Approval Date

Jan 7, 2026

Approval ID

2dfa7ad3516256ac

Type

Therapeutic

Back to HSA Approvals